Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene

NCT05630105 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 430

Last updated 2026-05-15

No results posted yet for this study

Summary

This is a multicentric, observational, retrospective and prospective study, aiming to estimate the risk of cancer occurrence in subjects carrying a PTEN mutation, based on the constitution of a national cohort.

Conditions

  • PTEN Gene Mutation

Sponsors & Collaborators

  • Institut Bergonié

    lead OTHER

Principal Investigators

  • Virginie BUBIEN, Dr · Institut Bergonié

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-12
Primary Completion
2048-01-31
Completion
2048-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05630105 on ClinicalTrials.gov